GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shilpa Medicare Ltd (BOM:530549) » Definitions » Beta

Shilpa Medicare (BOM:530549) Beta : 0.68 (As of Apr. 06, 2025)


View and export this data going back to 1995. Start your Free Trial

What is Shilpa Medicare Beta?

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2025-04-06), Shilpa Medicare's Beta is 0.68.


Shilpa Medicare Beta Historical Data

The historical data trend for Shilpa Medicare's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shilpa Medicare Beta Chart

Shilpa Medicare Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Beta
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.11 1.21 1.13 0.93 0.14

Shilpa Medicare Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.12 0.14 0.09 0.73 0.65

Competitive Comparison of Shilpa Medicare's Beta

For the Drug Manufacturers - Specialty & Generic subindustry, Shilpa Medicare's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shilpa Medicare's Beta Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shilpa Medicare's Beta distribution charts can be found below:

* The bar in red indicates where Shilpa Medicare's Beta falls into.


;
;

Shilpa Medicare Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.


Shilpa Medicare  (BOM:530549) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Shilpa Medicare Beta Related Terms

Thank you for viewing the detailed overview of Shilpa Medicare's Beta provided by GuruFocus.com. Please click on the following links to see related term pages.


Shilpa Medicare Business Description

Traded in Other Exchanges
Address
Hyderabad Road, Number 12-6-214/A-1, Shilpa House, Raichur, KA, IND, 584135
Shilpa Medicare Ltd is a specialty and generic drug manufacturer. The company's product range includes over 44 oncology and non-oncology APIs. It uses nano and micro technology in its drug identification and formulation. The operating segments of the company are Pharmaceutical products and services, which is the key revenue-generating segment; and Power sales. Geographically, the group derives revenue from India and Outside India, of which prime revenue is generated from India.

Shilpa Medicare Headlines

No Headlines